【摘要】：目的:腺樣體肥大是兒童常見的多發(fā)病,治療起來比較困難,病情容易反復(fù),長時間患病會影響兒童的身心健康發(fā)育,給孩子和家長帶來極大的痛苦和負(fù)擔(dān)。西醫(yī)藥物治療副作用大,依附性強(qiáng);西醫(yī)手術(shù)治療風(fēng)險較高,病情易反復(fù);中醫(yī)藥物治療見效慢,用藥困難。因此尋找一種不吃藥不手術(shù)的治療方法變得十分有現(xiàn)實意義。運動療法能夠提高人體機(jī)能,增強(qiáng)人體抵抗力,提高免疫系統(tǒng)功能。本文就是通過觀察游泳運動對腺樣體肥大的兒童病癥的影響,與藥物組進(jìn)行對比試驗,分析游泳運動對腺樣體肥大的治療機(jī)制,為臨床研究提供理論參考。方法:本實驗依托長春世紀(jì)游泳俱樂部融創(chuàng)館、吉大一院及市兒童醫(yī)院,選取2016年1月~4月在吉大一院及市醫(yī)院耳鼻喉科進(jìn)行門診治療的患病兒童36例�；疾和疃袒疾�4個月,最長患病14個月,年齡為6至8歲。實驗準(zhǔn)備期為4周,為2016年5月~6月,使實驗對象游泳水平基本保持一致,然后進(jìn)行分組。實驗前將符合納入標(biāo)準(zhǔn)的36名兒童按照患病程度隨機(jī)平均分成2組:藥物組和游泳組。實驗期為2016年7月~12月,分成2個療程,為1~10周,11~20周。藥物組選取藥物孟魯司特鈉片,化學(xué)名:白三稀受體拮抗劑(5mg),藥物組兒童不進(jìn)行專門的運動。游泳組制定合理有效的運動處方,游泳組的兒童不進(jìn)行除游泳以外的其他運動,除極特殊情況不服用藥物。分析兩組患病兒童的腺樣體體積積分、臨床癥狀積分,淋巴細(xì)胞、中性粒細(xì)胞比例、肺活量,并對治療效果進(jìn)行總結(jié)分析,使用SPSS20.0統(tǒng)計軟件進(jìn)行數(shù)據(jù)處理。結(jié)果:(1)通過20周實驗后,游泳組和藥物組臨床主要癥狀和次要癥狀的結(jié)果比較沒有顯著性差異P0.05,兩組組內(nèi)比較臨床主要癥狀和次要癥狀的結(jié)果比較均具有顯著性差異P0.05。(2)實驗后,游泳組和藥物組腺樣體體積積分結(jié)果比較沒有顯著性差異,P0.05,兩組組內(nèi)比較腺樣體體積積分結(jié)果比較均具有顯著性差異,P0.05。(3)實驗后,游泳組和藥物組患病兒童的中性粒細(xì)胞比例都恢復(fù)到了正常水平。針對淋巴細(xì)胞比例,游泳組均都恢復(fù)到了正常水平,而藥物組基本恢復(fù)到正常值。(4)實驗后,游泳組和藥物組的有效率和治愈率均較高,都達(dá)到了很好的治療效果。(5)實驗后,游泳組的兒童的肺活量明顯高于藥物組,具有顯著性差異P0.01。結(jié)論:游泳運動能達(dá)到藥物治療的效果,且不存在副作用。長期藥物治療會降低人體免疫系統(tǒng)功能,而游泳運動增強(qiáng)的人體的呼吸系統(tǒng)機(jī)能,提高了人體免疫力,對兒童腺樣體肥大癥具有很好的治療效果與干預(yù)機(jī)制。
[Abstract]:Objective: adenoid hypertrophy is a common frequent disease in children, which is difficult to treat and easy to repeat. It will affect the development of children's physical and mental health for a long time and bring great pain and burden to children and parents. Western medicine treatment of large side effects, strong dependence; Western surgery treatment risk is high, the disease is easy to repeat; traditional Chinese medicine treatment slow, difficult to use. Therefore, it is of great practical significance to find a treatment that does not take medicine or surgery. Exercise therapy can improve the function of human body, enhance human body resistance and improve the function of immune system. By observing the effect of swimming exercise on adenoid hypertrophy in children and comparing it with drug group, this paper analyzes the therapeutic mechanism of swimming exercise on adenoid hypertrophy, and provides a theoretical reference for clinical research. Methods: based on Changchun Century Swimming Club, Jida first Hospital and Children's Hospital, 36 children who were treated in the otolaryngology department and otolaryngology department from January to April 2016 were selected. Children with the disease have a minimum of 4 months and a maximum of 14 months, aged between 6 and 8 years. The preparation period of the experiment was 4 weeks, from May to June 2016. The swimming level of the subjects was basically the same, and then divided into groups. Before the experiment, 36 children who met the inclusion criteria were randomly divided into two groups according to the degree of illness: drug group and swimming group. The experimental period was from July to December, 2016, and was divided into two courses: 1: 10 weeks, 11: 20 weeks. Montelukast sodium tablets, chemical name: leukotriene receptor antagonist (5mg), were selected in the drug group, and children in the drug group were not given special exercise. The swimming group formulates reasonable and effective exercise prescriptions. Children in the swimming group do not exercise other than swimming and do not take drugs except in exceptional circumstances. The adenoid volume integral, clinical symptom score, lymphocyte, neutrophil ratio, vital capacity of the two groups were analyzed, and the therapeutic effect was summarized and analyzed. The data were processed by SPSS20.0 software. Results: (1) after 20 weeks of experiment, there was no significant difference between swimming group and drug group in the results of main clinical symptoms and secondary symptoms (P 0.05). There was significant difference between the main clinical symptoms and the secondary symptoms in the two groups (P 0.05). (2) after the experiment, there was no significant difference in the results of adenoid volume integral between the swimming group and the drug group. There were significant differences in the results of adenoid volume integral between the two groups. (3) after the experiment, the proportion of neutrophils in swimming group and drug group returned to normal level. According to the proportion of lymphocytes, the swimming group returned to the normal level, while the drug group basically returned to the normal value. (4) after the experiment, the effective rate and cure rate of the swimming group and the drug group were both higher. (5) after the experiment, the vital capacity of children in swimming group was significantly higher than that in drug group, with significant difference (P0.01). Conclusion: swimming exercise can achieve the effect of drug therapy, and there are no side effects. Long-term drug treatment can reduce the function of human immune system, while swimming can enhance human respiratory system function, improve human immunity, and have a good therapeutic effect and intervention mechanism for children with adenoid hypertrophy.
【學(xué)位授予單位】：吉林大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2017
【分類號】：G861.1

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 孫海波;汪敏;李章春;秦萍;周麗琴;張玉娟;;游泳運動與藥物綜合治療大鼠慢性非細(xì)菌性前列腺炎的病理學(xué)觀察[J];重慶醫(yī)學(xué);2016年13期

2 況曉波;;游泳運動對慢性支氣管炎大鼠肺組織MDA和SOD的影響[J];中國醫(yī)學(xué)創(chuàng)新;2014年25期

3 常昆鵬;曹華;;不同手術(shù)方式治療兒童腺樣體肥大的臨床療效分析[J];河南醫(yī)學(xué)研究;2014年02期

4 李旭;黃群;;非手術(shù)方法治療兒童腺樣體肥大的臨床觀察[J];臨床耳鼻咽喉頭頸外科雜志;2013年08期

5 陶佳;羅仁忠;溫瑞金;周麗楓;王潔;;糠酸莫米松治療小兒腺樣體肥大的短期療效評估[J];兒科藥學(xué)雜志;2013年04期

6 何敏;蘇正輝;彭榮春;余承瑤;范永強(qiáng);;兒童OSAHS合并ADHD行扁桃體、腺樣體切除術(shù)后療效分析[J];中國社區(qū)醫(yī)師(醫(yī)學(xué)專業(yè));2012年35期

7 王薇;張呼和;;3種不同術(shù)式治療兒童腺樣體肥大的療效分析[J];中國耳鼻咽喉頭頸外科;2012年06期

8 張麗芬;郭玉萍;周軍;茹凱;趙波;孫曉姣;;運動對人體自由基代謝的影響[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2012年17期

9 朱美華;王志堅;溫紅艷;梁敏;;白三烯受體拮抗劑治療兒童腺樣體肥大臨床研究[J];中國實用兒科雜志;2011年11期

10 陳貴華;周向東;胡曉;劉益群;李琪;;運動療法改善慢性阻塞性肺疾病患者的生活質(zhì)量和肺功能[J];中南大學(xué)學(xué)報(醫(yī)學(xué)版);2011年07期

，

本文編號：2304072